216 related articles for article (PubMed ID: 12401863)
1. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome.
Day CJ; Cockwell P; Lipkin GW; Savage CO; Howie AJ; Adu D
Nephrol Dial Transplant; 2002 Nov; 17(11):2011-3. PubMed ID: 12401863
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
Gargah TT; Lakhoua MR
J Nephrol; 2011; 24(2):203-7. PubMed ID: 21319130
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
[TBL] [Abstract][Full Text] [Related]
6. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[TBL] [Abstract][Full Text] [Related]
8. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S; Hirano D; Nishino T; Umeda C; Watanabe Y; Nakagawa M
Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
[TBL] [Abstract][Full Text] [Related]
10. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.
Chandra M; Susin M; Abitbol C
Pediatr Nephrol; 2000 Mar; 14(3):224-6. PubMed ID: 10752763
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U; Weber LT
Pediatr Nephrol; 2018 Dec; 33(12):2253-2265. PubMed ID: 29750317
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.
Tasanarong A; Thitiarchakul S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.
Chan MK; Cheng IK
Postgrad Med J; 1987 Sep; 63(743):757-9. PubMed ID: 3444800
[TBL] [Abstract][Full Text] [Related]
14. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.
Gellermann J; Querfeld U
Pediatr Nephrol; 2004 Jan; 19(1):101-4. PubMed ID: 14753204
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[TBL] [Abstract][Full Text] [Related]
16. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):528-31. PubMed ID: 11809115
[TBL] [Abstract][Full Text] [Related]
17. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
[TBL] [Abstract][Full Text] [Related]
18. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
[No Abstract] [Full Text] [Related]
19. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome.
Afzal K; Bagga A; Menon S; Hari P; Jordan SC
Pediatr Nephrol; 2007 Dec; 22(12):2059-65. PubMed ID: 17938973
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]